About conference
The 33rd World Diabetes & Heart Congress is an international conference that will be held on September 28–29, 2027, in Amsterdam, Netherlands. The congress aims to inspire new strategies and foster global partnerships to address the growing challenges of diabetes and cardiovascular diseases. It brings together healthcare professionals, researchers, and experts to discuss the latest advancements in diabetes and cardiovascular health.
The conference focuses on improving prevention, diagnosis, and treatment through research, innovation, and collaboration, while providing a valuable platform for knowledge sharing and networking. It will feature keynote presentations, scientific sessions, panel discussions, and workshops led by renowned experts from around the world. A wide range of topics will be covered, including diabetes management, cardiovascular diseases, emerging therapies, digital health technologies, and integrated care approaches. Participants will have the opportunity to present their research, exchange ideas, and build professional connections in a collaborative environment.
The congress will also highlight the importance of multidisciplinary approaches in addressing the connection between diabetes and cardiovascular complications. Experts will share evidence-based practices, clinical experiences, and innovative strategies aimed at enhancing patient outcomes, promoting early intervention, and reducing the global burden of chronic diseases. In addition, the event will encourage collaboration between academic institutions, healthcare organizations, pharmaceutical professionals, and industry representatives. It will provide an excellent opportunity for young researchers and experienced professionals to showcase their work, gain valuable insights, explore emerging research opportunities, and establish meaningful international collaborations.
Join us in Amsterdam for two days of scientific discussions, knowledge exchange, and professional networking as we work together toward a healthier future through innovation and advancements in diabetes and cardiovascular care.
Target audiences
Certainly, here are the main target audiences for the Diabetes & Heart Congress:
• Hospitals and Multispecialty Healthcare Centers
• Cardiologists and Cardiac Surgeons
• Diabetologists and Endocrinologists
• General Physicians and Internal Medicine Specialists
• Researchers and Academic Institutions
• Diabetes Educators and Certified Counselors
• Nurses, Clinical Technicians, and Healthcare Professionals
• Experts in Preventive Cardiology and Lifestyle Medicine
• Pharmaceutical and Biopharmaceutical Companies
• Medical Device and Diagnostic Equipment Manufacturers
• Digital Health and Remote Monitoring Companies
• Artificial Intelligence and Healthcare Data Analytics Specialists
• Nutritionists, Dietitians, and Wellness Coaches
• Rehabilitation and Cardiac Care Centers
• Public Health Organizations and Government Health Agencies
• Clinical Researchers and Translational Medicine Experts
• Health Insurance Providers and Healthcare Payers
• Telemedicine and Virtual Care Providers
• Laboratory and Diagnostic Service Providers
• Experts in Obesity, Metabolic Syndrome, and Preventive Healthcare
• Fitness, Exercise Physiology, and Sports Medicine Professionals
• Professional Medical Associations and Healthcare Societies
• Pharmacovigilance and Drug Safety Specialists
• Experts in Precision Medicine and Personalized Healthcare
Sessions and Tracks
The 33rd World Diabetes & Heart Congress 2027 welcomes healthcare professionals, medical researchers, academicians, clinicians, industry experts, and students to participate in a comprehensive scientific program covering the latest developments in diabetes, cardiovascular medicine, clinical research, and healthcare innovation.
The congress provides an international platform for oral presentations, keynote lectures, scientific discussions, poster presentations, and professional networking. Participants are encouraged to share original research, clinical findings, innovative treatment approaches, and evidence-based practices that contribute to improving diabetes and cardiovascular care.
1. Diabetes and Metabolic Disorders
Explore the latest scientific developments in diabetes research, metabolic syndrome, insulin resistance, beta-cell dysfunction, and glucose regulation. This session focuses on disease mechanisms, early diagnosis, advanced screening methods, glycemic control, and comprehensive diabetes management. Researchers and clinicians are encouraged to present findings that support better prevention, treatment, and long-term patient care.
2. Cardiovascular Complications in Diabetes
This session examines the complex relationship between diabetes and cardiovascular diseases, including coronary artery disease, heart failure, hypertension, atherosclerosis, and vascular dysfunction. Discussions will highlight cardiovascular risk assessment, preventive cardiology, integrated diabetes and heart care, and emerging treatment strategies for reducing cardiovascular complications.
3. Clinical Research and Therapeutic Innovations
Discover recent developments in clinical trials, drug discovery, pharmacological interventions, and personalized medicine for diabetes and cardiovascular diseases. Topics include novel antidiabetic medications, cardiovascular protective therapies, combination treatments, precision medicine, clinical trial outcomes, and evidence-based treatment guidelines. Original clinical research and therapeutic studies are particularly encouraged.
4. Digital Health, Artificial Intelligence and Medical Technology
This session highlights the growing role of digital innovation in modern healthcare. It covers artificial intelligence, machine learning, predictive analytics, wearable medical devices, continuous glucose monitoring, telemedicine, and remote patient monitoring. Presentations may explore how emerging technologies improve early diagnosis, treatment decisions, disease monitoring, and personalized patient care.
5. Diabetes Complications and Multi-Organ Health
Focus on the prevention, diagnosis, and management of diabetes-related complications affecting multiple organ systems. Key topics include diabetic neuropathy, nephropathy, retinopathy, diabetic foot complications, kidney disease, and cardiovascular damage. Researchers are invited to present clinical studies and innovative approaches to reducing long-term complications and improving patient outcomes.
6. Diabetic Nursing and Patient-Centered Care
This session recognizes the essential role of nursing professionals in diabetes education, monitoring, treatment adherence, and chronic disease management. Topics include patient counseling, insulin administration, blood glucose monitoring, lifestyle education, diabetic wound care, multidisciplinary coordination, and community-based diabetes management. Nursing professionals and healthcare educators are encouraged to share their clinical experiences and research findings.
7. Diabetes Devices and Medical Technology
Explore technological advancements transforming diabetes diagnosis, monitoring, and treatment. This track includes continuous glucose monitoring systems, insulin pumps, smart insulin delivery devices, digital diabetes applications, glucometers, automated insulin delivery systems, and connected healthcare solutions. Researchers and industry professionals can showcase innovative devices, product developments, and clinical applications.
8. Emerging Research and Translational Medicine
This session focuses on innovative scientific discoveries and their potential clinical applications in diabetes and cardiovascular medicine. Areas of interest include genomics, proteomics, molecular biology, stem cell research, regenerative medicine, biomarkers, gene-based therapies, and precision healthcare. The session encourages researchers to present novel findings that bridge laboratory research and clinical practice.
9. Nutrition, Lifestyle and Preventive Medicine
Examine the importance of nutrition, physical activity, weight management, and behavioral interventions in preventing and controlling diabetes and cardiovascular diseases. Topics include medical nutrition therapy, obesity prevention, dietary interventions, metabolic health, exercise-based rehabilitation, public health strategies, and lifestyle modification programs. This session welcomes contributions from nutritionists, dietitians, public health researchers, and healthcare professionals.
10. Diabetes Mellitus: Mechanisms, Diagnosis and Management
This session provides an in-depth overview of Type 1 diabetes, Type 2 diabetes, gestational diabetes, and other forms of diabetes mellitus. Discussions will cover disease classification, insulin deficiency, insulin resistance, diagnostic criteria, glucose monitoring, treatment approaches, and recent advances in diabetes management. Researchers are encouraged to share clinical studies and innovative approaches to improving disease control.
11. Pathophysiology and Molecular Mechanisms of Diabetes
Explore the cellular, biochemical, genetic, and molecular mechanisms involved in diabetes development and progression. Topics include insulin signaling pathways, pancreatic beta-cell dysfunction, glucose metabolism, inflammation, oxidative stress, hormonal regulation, and genetic susceptibility. This track offers opportunities for basic science researchers and clinical investigators to present experimental and translational research.
12. Cardiology and Cardiovascular Medicine
This session covers current developments in the diagnosis, prevention, and treatment of cardiovascular diseases. Areas of interest include coronary artery disease, hypertension, arrhythmias, myocardial infarction, heart failure, vascular disorders, and preventive cardiology. Cardiologists, physicians, and clinical researchers are invited to share recent findings, treatment approaches, and evidence-based clinical practices.
13. Heart Devices and Cardiovascular Technology
Discover innovative technologies and medical devices transforming cardiovascular diagnosis and treatment. Topics include cardiac pacemakers, implantable cardioverter-defibrillators, cardiac monitoring systems, artificial heart technologies, advanced imaging, catheter-based interventions, and minimally invasive cardiovascular procedures. Presentations highlighting technological innovation and clinical applications are welcome.
14. Pediatric Cardiology and Congenital Heart Diseases
This track focuses on cardiovascular conditions affecting infants, children, and adolescents. Topics include congenital heart defects, pediatric arrhythmias, inherited cardiac disorders, childhood hypertension, diagnostic imaging, and advances in pediatric cardiac interventions. Pediatric cardiologists and researchers are encouraged to present clinical experiences and research addressing early diagnosis and improved treatment outcomes.
15. Cardiac Regeneration and Advanced Cardiovascular Therapies
Explore emerging approaches to repairing damaged cardiac tissue and improving heart function. Topics include stem cell-based therapies, tissue engineering, regenerative medicine, cellular therapies, biomaterials, and emerging approaches to myocardial repair. Researchers are encouraged to present experimental findings and translational studies examining the future potential of cardiac regeneration.
16. Cardiology Case Reports and Clinical Experiences
This session provides a platform for presenting unique, rare, and challenging cardiovascular cases. Topics may include unusual cardiac presentations, complex diagnostic conditions, treatment complications, innovative interventions, and multidisciplinary case management. Physicians, cardiologists, and medical professionals can share practical clinical insights and lessons that contribute to improved patient care.
17. Obesity, Stroke and Metabolic Health
Examine the relationship between obesity, metabolic disorders, stroke, and cardiovascular risk. Topics include obesity-related insulin resistance, metabolic syndrome, hypertension, ischemic stroke, weight management, bariatric surgery, and preventive interventions. Research on the impact of lifestyle modification and multidisciplinary treatment strategies is encouraged.
18. Cardiovascular Diagnosis and Pharmacological Management
This session highlights advances in cardiovascular diagnostic methods and medication-based treatment strategies. Topics include electrocardiography, echocardiography, cardiac biomarkers, advanced cardiovascular imaging, antihypertensive medications, anticoagulants, lipid-lowering therapies, and evidence-based pharmacological interventions. Contributions addressing treatment safety, clinical effectiveness, and personalized medication management are welcome.
19. Integrated Care, Rehabilitation and Long-Term Disease Management
This track explores coordinated approaches to managing patients with diabetes and cardiovascular diseases. Discussions will include multidisciplinary healthcare models, cardiac rehabilitation, patient education, medication adherence, remote monitoring, chronic disease follow-up, and strategies for improving quality of life. Healthcare professionals are invited to share successful care models and practical clinical experiences.
20. Public Health, Epidemiology and Global Health Challenges
This session addresses the growing worldwide burden of diabetes and cardiovascular diseases through epidemiological research, population-based studies, healthcare policies, disease prevention programs, and community health initiatives. Topics include global disease trends, healthcare accessibility, health inequalities, early screening, awareness campaigns, and strategies for strengthening public health systems.
Market analysis
The global market for diabetes and cardiovascular medical devices represents a rapidly expanding sector in healthcare. According to recent figures from the International Diabetes Federation (IDF), the worldwide market for diabetes care devices, including insulin delivery systems, glucose monitoring devices, and cardiovascular therapeutic gadgets, exceeded $55 billion in 2025, with a projected annual growth rate of 6–7% over the next five years. The U.S., Europe, and Japan remain the largest regional markets, with emerging demand in Asia-Pacific and Middle East markets due to increasing prevalence of diabetes and cardiovascular diseases.
The diabetes segment includes continuous glucose monitoring (CGM) systems, insulin pumps, smart pens, test strips, and wearable monitoring devices, which are increasingly integrated with digital platforms for real-time data tracking and telemedicine applications. Meanwhile, the cardiology segment comprises pacemakers, implantable cardioverter-defibrillators (ICDs), stents, balloon catheters, cardiac imaging devices, and heart failure assist devices.
The global cardiovascular devices market in 2025 was valued at approximately $68 billion, driven by rising incidence of coronary artery disease, heart failure, and arrhythmias. Subsegments include coronary stents, angioplasty balloons, intravascular imaging catheters (IVUS, OCT), guide wires, introducer sheaths, and fractional flow reserve (FFR) guide wires.
The 2026 diabetes and cardiovascular healthcare market shows strong growth, driven by increasing diabetes cases, rising cardiovascular diseases, medical research, advanced treatments, and digital healthcare technologies. Key areas of interest include diabetes management, cardiology, clinical research, AI-based diagnosis, medical devices, and preventive healthcare.
The market is expected to continue its growth trajectory due to:
-
Aging populations in developed countries with high incidence of diabetes and heart disease.
-
Increased prevalence of lifestyle-related diseases such as obesity, hypertension, and type 2 diabetes in developing regions.
-
Technological innovation, including AI-assisted diagnostic tools, minimally invasive devices, and wearable monitoring technologies.
-
Regulatory support and reimbursement programs that facilitate adoption of advanced medical devices.
Conclusion: The integrated diabetes and cardiology devices market presents a significant opportunity for innovation, research, and industry engagement, making conferences like the 33rd World Diabetes & Heart Congress – Expert Meets 2027, scheduled for September 28-29, 2027, in Amsterdam, Netherlands, an essential platform for showcasing technology, facilitating partnerships, and advancing clinical knowledge globally.